Intelligent Infusion Management System Companies, Latest Updates and Market Growth 2026

Latest Updates of Key Players in the Intelligent Infusion Management System Market

Genetic Stability Testing Services – Key Company Updates

Becton, Dickinson and Company

Headquarters: United States
Latest Update: In October 2025, BD introduced the BD Incada Connected Care Platform, a scalable, AI-driven, cloud-based platform that unifies BD device data into a single intelligent ecosystem for the first time.

Baxter International Inc.

Headquarters: United States
Latest Update: Baxter now has integrations live across the three largest EMR systems in the U.S. and recently completed the first-ever EMR integration with a customer.

B. Braun SE

Headquarters: Germany
Latest Update: In July 2025, B. Braun Medical Inc. announced the launch of Heparin Sodium Injections in the U.S., expanding its portfolio to include 25,000 Units Heparin in 0.45% Sodium Chloride Injection (100 units/mL).

ICU Medical, Inc.

Headquarters: United States
Latest Update: In April 2025, ICU Medical received 510(k) FDA clearance for the Plum Solo precision IV pump, a single-channel complement to the Plum Duo system.

Fresenius Kabi AG

Headquarters: Germany
Latest Update: Fresenius Kabi and Mayo Clinic signed a multiyear contract for the Ivenix Infusion System.

Medtronic plc

Headquarters: United States
Latest Update: In May 2025, Medtronic announced its intent to separate its Diabetes business into a new standalone company.

Market Growth

The global intelligent infusion management system market size was estimated at USD 1.15 billion in 2025 and is predicted to increase from USD 1.23 billion in 2026 to approximately USD 2.29 billion by 2035, expanding at a CAGR of 7.14% from 2026 to 2035.

Recent Developments in the Intelligent Infusion Management System Market

• In September 2025, FFF Enterprises, Inc., the nation’s most trusted specialty drug distributor and diversified healthcare company, announced the exciting launch of RightNow Anywhere through RightNow Inventory (RNI), a subsidiary of FFF that grows intelligent inventory management devices and technology services.
• In July 2025, Wishpro launched its first patented Magnetic Infusion Technology (MIT) system, engineered to deliver visible skin transformation.
• In November 2025, Biogen Inc. completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative CNS therapy delivery solutions, such as the ThecaFlex DRx drug delivery system.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com